Totally Totipotent:  New technology promises food security, rescue of endangered species and major medical advances 

Prescient TBI, Inc. of Massachusetts announces the advent of an unprecedented, novel technology for rapid, mass production of complete, animal embryos. 

This unique process enables millions of embryos to be produced from non-germ line cells in only a few days.

Mass production of animal embryos has profound implications for global food security-including restoration of depleted fish stocks. The technology also offers new hope for rescuing threatened and endangered species from extinction.   

Likewise, the ability to produce totipotent cells and complete embryos turns the dream of  personalized medicine into reality. It also dramatically simplifies the generation of transgenic animals, and surmounts a major barrier to full regenerative medicine approaches.

In addition to commercial activities, Prescient TBI intends to collaborate with the inventors / licensors of this technology to establish an international, non-profit to work with various local and national governments, in addition to non-governmental organizations, so as to ensure the technology is employed responsibly and for the benefit of all.

Food security, species conservation, and health improvement are essential elements in the pursuit of a better world.  Prescient welcomes offers of collaboration and support aimed at helping to achieve it.

More information:
880 N. Alameda St
312
Los Angeles, CA 90012

310 663 2062

Provided by Prescient TBI, Inc